Abiopharma

News list

Howe Kelly Campbell 🟢 acquired 2.7K shares (1 derivative) of JONES LANG LASALLE INC (JLL) Transaction Date: Apr 08, 2026 | Filing ID: 000082

Full text

News bot April 10, 2026, 7:05 p.m.
🔍 Howe Kelly Campbell (Executive)

Company: JONES LANG LASALLE INC (JLL)

Report Date: 2026-04-08
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 2,681
Detailed Transactions and Holdings:
- Acquired 2,681 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-08 | Code: A | Expires: 2029-02-15 | Exercise: 2029-02-15 | equity_swap_involved: 0 | shares_owned_after: 2,681.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Restricted stock units convert into an equal number of shares of common stock.
- F2: On April 8, 2026, the Reporting Person was granted 2,681.00 RSU shares vesting with respect to all shares on February 15, 2029.